We are live on ! Find out more
VFA

Virtus Fund Advisers Portfolio holdings

AUM $32.1M
1-Year Est. Return 39.5%
This Fund
S&P 500
This Quarter Est. Return
+16.04%
1 Year Est. Return
+39.5%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$16.1M
AUM Growth
+$1.99M
Cap. Flow
-$24.4K
Cap. Flow %
-0.15%
Top 10 Hldgs %
70.44%
Holding
120
New
20
Increased
5
Reduced
20
Closed
15

Top Buys

Rank Stock Value
1
CMPR icon
Cimpress
CMPR
+$412K
2
THO icon
Thor Industries
THO
+$74.9K
3
P
Everpure Inc
P
+$61.6K
4
BL icon
BlackLine
BL
+$61.4K
5
STRA icon
Strategic Education
STRA
+$60.6K

Sector Composition

Rank Sector Weight
1 Financials 18.37%
2 Materials 16.64%
3 Consumer Discretionary 14.42%
4 Energy 13.74%
5 Industrials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZYME icon
76
Zymeworks
ZYME
$1.62B
$32.2K 0.2%
+3,100
New +$24.7K
MBC icon
77
MasterBrand
MBC
$1.08B
$31.8K 0.2%
2,141
YOU icon
78
Clear Secure
YOU
$5.82B
$30.8K 0.19%
+1,491
New +$29K
INTA icon
79
Intapp
INTA
$2.44B
$30.7K 0.19%
807
-1,318
-62% -$48.5K
TK icon
80
Teekay
TK
$995M
$30.3K 0.19%
4,242
BCSF icon
81
Bain Capital Specialty
BCSF
$826M
$30.2K 0.19%
2,007
BZH icon
82
Beazer Homes USA
BZH
$890M
$30K 0.19%
889
-597
-40% -$16.3K
SWAV
83
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$29.7K 0.18%
156
CHGG icon
84
Chegg
CHGG
$118M
$29.3K 0.18%
+2,583
New +$24.5K
PEGA icon
85
Pegasystems
PEGA
$5.01B
$29.3K 0.18%
1,200
FELE icon
86
Franklin Electric
FELE
$4.68B
$28.8K 0.18%
298
-586
-66% -$52.6K
NARI
87
DELISTED
Inari Medical, Inc. Common Stock
NARI
$28.5K 0.18%
439
-174
-28% -$10.5K
WNC icon
88
Wabash National
WNC
$535M
$28K 0.17%
1,091
BPMC
89
DELISTED
Blueprint Medicines
BPMC
$27.9K 0.17%
303
-215
-42% -$13.9K
CLBT icon
90
Cellebrite
CLBT
$3.72B
$27.9K 0.17%
+3,221
New +$25K
HALO icon
91
Halozyme
HALO
$9.85B
$27.7K 0.17%
750
VCEL icon
92
Vericel Corp
VCEL
$2.36B
$27.3K 0.17%
766
ATRC icon
93
AtriCure
ATRC
$2.05B
$26.8K 0.17%
+752
New +$28K
EVBG
94
DELISTED
Everbridge, Inc. Common Stock
EVBG
$25.1K 0.16%
1,031
TAC icon
95
TransAlta
TAC
$3.94B
$24.9K 0.15%
2,997
TCMD icon
96
Tactile Systems Technology
TCMD
$616M
$23.3K 0.14%
+1,631
New +$20.5K
SUPN icon
97
Supernus Pharmaceuticals
SUPN
$2.71B
$20.7K 0.13%
714
STRO icon
98
Sutro Biopharma
STRO
$384M
$18.9K 0.12%
441
SAIA icon
99
Saia
SAIA
$10.5B
$17.5K 0.11%
40
-110
-73% -$44.4K
CPRX
100
DELISTED
Catalyst Pharmaceutical
CPRX
$17.3K 0.11%
1,028

Similar funds

Virtus Fund Advisers's Q4 2023 Portfolio in Review

As of Q4 2023, Virtus Fund Advisers held 120 positions worth $16.1M, up 14% from $14.1M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Virtus Fund Advisers's Q4 2023 filing shows 20 new, 5 increased, 20 reduced and 15 closed positions. Its largest new stake was Cimpress: 5,919 shares worth $474K. The largest sale was Commercial Metals, an estimated $130K.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Materials and Consumer Discretionary.

  • Virtus Fund Advisers's largest Q4 2023 buy was Cimpress: 5,919 shares worth $474K.
  • Virtus Fund Advisers added most to Everpure Inc in Q4 2023, an estimated $61.6K increase.
  • Virtus Fund Advisers's biggest Q4 2023 reduction was Applied Industrial Technologies, cutting an estimated $53.4K.
  • Virtus Fund Advisers fully exited Commercial Metals in Q4 2023, selling an estimated $130K.
  • Virtus Fund Advisers's ten largest holdings make up 70% of its $16.1M portfolio in Q4 2023.
  • Virtus Fund Advisers opened 20 new positions and closed 15 in Q4 2023.
  • Virtus Fund Advisers's portfolio value rose 14% quarter-over-quarter to $16.1M.

Based on Virtus Fund Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.